The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
Abstract
Incretin-based therapies, including GLP-1 receptor agonists and dual GLP-1-GIP receptor agonists, have transformed obesity management, producing substantial weight loss and cardiometabolic benefits, with potential improvements in obesity-related complications, physical function, quality of life, and psychological wellbeing for many individuals. However, reduced appetite, rapid weight loss, gastrointestinal adverse effects, and changes in eating behaviour might create nutritional, functional, or psychological risks in some individuals. This EASO-EFAD-ECPO Consensus Statement outlines pragmatic nutritional, functional, and psychological considerations during incretin-based therapy treatment. We synthesise evidence on medical nutrition therapy, including protein targets during weight loss, dietary quality, and mitigation of gastrointestinal adverse events. We discuss pragmatic approaches that could help support preservation of fat-free mass and physical function during weight loss, including adequate protein intake and progressive resistance exercise. We emphasise the psychological and identity-related challenges during incretin-based therapy, including shifts in food reward, coping, and social connection, and recommend psychological screening, with integrated support where needed. We propose pragmatic monitoring during weight loss, including diet quality, micronutrient risk, and functional measures, with body-composition assessment where indicated. We suggest approaches to addr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Self-citationTirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.002 · Cited by 3,022
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic, V., Tuttle, K. R., Rossing, P., Mahaffey, K. W., Mann, J. F. E., Bakris, G., Baeres, F. M. M., Idorn, T., Bosch-Traberg, H., Lausvig, N. L., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2403347 · Cited by 2,099
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306963 · Cited by 1,669
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444
Research works printed but not linked: 4
- 2015, Scientific opinion on the essential composition of total diet replacements for weight control, EFSA J, 13
- 2016, Scientific opinion on dietary reference values for carbohydrates and dietary fibre, EFSA J, 8
- 2016, Scientific opinion on dietary reference values for water, EFSA J, 8
- Neeland, 2024, Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies, Diabetes Obes Metab, 26, 16, 10.1111/dom.15728 · DOI · Paper page
Cited by
Gracioto, P. G. A., de Oliveira, J. C. M., & Oliveira, C. R. (2026) · Research Society and Development · doi:10.33448/rsd-v15i7.51444
Balasubaramaniam, V., Scobie, M., O’Kane, M. P. M., Graham, Y., Robertson, A. G., & Mahawar, K. K. (2026) · Nutrients · doi:10.3390/nu18162643
“Joint advisory recommends approximately 1.2–1.6 g/kg/day of protein, while the 2026 European Association for the Study of Obesity expert consensus suggests considering a target of 1.0–1.5 g/kg adjusted body weight/day during weight loss with incretin-based therapies [31,70].”
InfluentialBeyond One-Size-Fits-All: Individually Tailored Dietary Interventions in Modern Obesity Care
Cozma-Petruț, A. P., Gherghel, M., Banc, R., Tișa, I. B., Stanciu, O., Coldea, T. E., Mudura, E., Miere, D., & Filip, L. A. (2026) · Nutrients · doi:10.3390/nu18162691 · Cited by 1
Caturano, A., Mocini, E., Titi, L., Leva, F., Cannavaro, D., Tarsitano, M. G., & Conte, C. (2026) · Nutrients · doi:10.3390/nu18172933
“Similar attention to protein intake, nutrient density, resistance exercise, and muscle-function monitoring is recommended for patients receiving incretin-based therapy [93,94].”
Ding, W., Liu, Q., Luo, Q., Yao, X.-J., & Fan, X.-X. (2026) · Diabetes, obesity and metabolism · doi:10.1111/dom.71304
Metadata
- Authors
- Dobbie, L. J., Tolvanen, L., Alves, D., Baker, J. L., Bez, N. S., Birney, S., Bogl, L. H., Brown, A., Bullo, M., Clare, K., Duncan, E. L., Govers, E., Mooney, V., Mulrooney, H., Mercado, D. O., O’Malley, G., Oppert, J.-M., Pillinger, T., Remijnse, W., Shuttlewood, E., Wakolbinger, M., Woodward, E., Yumuk, V. D., Hassapidou, M., Ciudin, A., & McGowan, B.
- Affiliations
- King's College London (GB)
- Mayo Clinic (US)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Bispebjerg Hospital (DK)
- Bern University of Applied Sciences (CH)
- University College Hospital (GB)
- London Metropolitan University (GB)
- Ospedale Koelliker (IT)
- Inserm (FR)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- European Association for the Study of Obesity (GB)
- Istanbul University-Cerrahpaşa (TR)
- International Hellenic University (GR)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Dobbie, Laurence J
- ORCID
- Dobbie, Laurence J
- Tolvanen, Liisa
- Baker, Jennifer L
- Bez, Natalie S
- Birney, Susie
- Bogl, Leonie H
- Brown, Adrian
- Clare, Ken
- Duncan, Emma L
- Mooney, Vicki
- Mulrooney, Hilda
- Mercado, Daniela Ojeda
- Oppert, Jean-Michel
- Pillinger, Toby
- Remijnse, Wineke
- Shuttlewood, Emma
- Wakolbinger, Maria
- Yumuk, Volkan D
- Hassapidou, Maria
- Ciudin, Andreea
- McGowan, Barbara
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2026-09
- Volume
- 14
- Issue
- 9
- Pages
- 754-777
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W7167682649
- Cited by
- 8
- References
- 187
- Citations by year
- 2026: 8
- FWCI
- 33.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- UKRI Medical Research Council
- National Institute for Health Research
- Rosetrees Trust
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- incretin-based therapy, GLP-1 receptor agonists, GIP/GLP-1 receptor agonist, obesity treatment, weight loss, medical nutrition therapy, protein intake, physical function, gastrointestinal adverse effects, eating behaviour, food reward, psychological well-being, body image, body composition, shared decision-making, medication adherence, access to treatment, quality of life
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Humans, Obesity, Quality of Life, Weight Loss, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement. https://app.cochat.ai/papers/10.1016/s2213-8587(26)00122-1
- The paper
- Dobbie, L. J., Tolvanen, L., Alves, D., Baker, J. L., Bez, N. S., Birney, S., Bogl, L. H., Brown, A., Bullo, M., Clare, K., Duncan, E. L., Govers, E., Mooney, V., Mulrooney, H., Mercado, D. O., O’Malley, G., Oppert, J.-M., Pillinger, T., Remijnse, W., . . . McGowan, B. (2026). Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(26)00122-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.